跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Njectxime 500 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Njectxime 500
Approved
STANDARD
Njectxime 500
Scott-Edil Advance Research Laboratories & Education Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cc378188e06a0828
Company
Scott-Edil Advance Research Laboratories & Education Ltd.
Type
Standard
Approval Details
Approval Id
cc378188e06a0828
Drug Approval Philippines Name
Njectxime 500
Product Name
Njectxime 500
Registration Number
DRP-5017-05
Brand Name
Njectxime 500
Generic Name
Cefuroxime (as axetil)
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Scott-Edil Advance Research Laboratories & Education Ltd.
Importer
Pharmakon Biotec, Inc.
Distributor
NJT ENTERPRISES
Issuance Date
24 January 2024
Expiry Date
18 December 2028
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cc378188e06a0828
Type
Standard
Back to Philippines FDA Approvals